[{"image":"https://icons.cdn.biorender.com/w75xh75/606c7a3fc6644b0028d7d2cc/606c79f5c6644b0028d7d2bd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/606c7a3fc6644b0028d7d2cc/606c79f5c6644b0028d7d2bd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/606c7a3fc6644b0028d7d2cb/606c79f5c6644b0028d7d2bd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/606c7a3fc6644b0028d7d2cb/606c79f5c6644b0028d7d2bd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/606c7a3fc6644b0028d7d2ca/606c79f5c6644b0028d7d2bd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/606c7a3fc6644b0028d7d2ca/606c79f5c6644b0028d7d2bd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/606c7a3fc6644b0028d7d2c9/606c79f5c6644b0028d7d2bd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/606c7a3fc6644b0028d7d2c9/606c79f5c6644b0028d7d2bd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/606c7a3fc6644b0028d7d2c8/606c79f5c6644b0028d7d2bd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/606c7a3fc6644b0028d7d2c8/606c79f5c6644b0028d7d2bd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/606c7a3fc6644b0028d7d2c7/606c79f5c6644b0028d7d2bd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/606c7a3fc6644b0028d7d2c7/606c79f5c6644b0028d7d2bd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/606c7a3fc6644b0028d7d2c6/606c79f5c6644b0028d7d2bd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/606c7a3fc6644b0028d7d2c6/606c79f5c6644b0028d7d2bd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/606c7a3fc6644b0028d7d2c5/606c79f5c6644b0028d7d2bd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/606c7a3fc6644b0028d7d2c5/606c79f5c6644b0028d7d2bd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/606c7a3fc6644b0028d7d2c4/606c79f5c6644b0028d7d2bd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/606c7a3fc6644b0028d7d2c4/606c79f5c6644b0028d7d2bd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/606c7a3fc6644b0028d7d2c3/606c79f5c6644b0028d7d2bd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/606c7a3fc6644b0028d7d2c3/606c79f5c6644b0028d7d2bd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/606c7a3fc6644b0028d7d2c2/606c79f5c6644b0028d7d2bd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/606c7a3fc6644b0028d7d2c2/606c79f5c6644b0028d7d2bd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/606c7a3fc6644b0028d7d2c1/606c79f5c6644b0028d7d2bd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/606c7a3fc6644b0028d7d2c1/606c79f5c6644b0028d7d2bd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/606c7a3fc6644b0028d7d2c0/606c79f5c6644b0028d7d2bd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/606c7a3fc6644b0028d7d2c0/606c79f5c6644b0028d7d2bd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/606c7a3fc6644b0028d7d2bf/606c79f5c6644b0028d7d2bd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/606c7a3fc6644b0028d7d2bf/606c79f5c6644b0028d7d2bd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/606c7a3fc6644b0028d7d2be/606c79f5c6644b0028d7d2bd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/606c7a3fc6644b0028d7d2be/606c79f5c6644b0028d7d2bd.png"}]